The “Drug Discovery and Cell Therapy” group led by Dr. Roberto Motterlini (Equipe 12) is looking for a highly skilled and enthusiastic post-doctoral fellow working in a dynamic, international and interactive environment. The position is available starting from 1 November 2018 and will be funded for 1 year by an International grant from the Agence Nationale de la Recherche (ANR).
The laboratory is conducting research on the therapeutic properties of the heme oxygenase-1 (HO-1)/carbon monoxide pathway in the cardiovascular system and inflammation and aims at exploiting this pathway as a target for the discovery of new pharmacological approaches. The project will focus on examining the effect of new chemical entities on skin wound healing and inflammation, working in close collaboration with chemists in order to tailor these compounds for this specific therapeutic application. The successful candidate will be integrated in a multidisciplinary environment embracing chemistry, biology and pharmacology.
Highly motivated and dynamic candidates are encouraged to apply and should have a PhD with strong skills in models of wound healing, inflammation and angiogenesis. The candidate will have proven experience in a variety of methodological approaches including molecular biology, biochemical assays and immunohistochemistry/immunofluorescence techniques and must have experience with in vivo models and analyses of tissue samples. Candidates should also be able to apply their skills and scientific knowledge in the context of diabetic wound healing.
Interested applicants should email a Curriculum Vitae indicating the project acronym (CO-HEAL) with a letter of motivation, research interests, technical skills and the name and email of three referees to: Dr. Roberta Foresti, Faculty of Medicine, University Paris-Est Creteil, France; email@example.com.
Closing date for applicants: 15 August 2017Lire la suite